Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fady Tawadros"'
Publikováno v:
Oncology Reviews, Vol 11, Iss 1 (2017)
Induction of apoptosis in cancer cells has increasingly been the focus of many therapeutic approaches in oncology field. Since its identification as a TNF family member, TRAIL (TNF-related apoptosis-inducing ligand) paved a new path in apoptosis indu
Externí odkaz:
https://doaj.org/article/6cd5fd59348f42e6832e8037cca4e090
Autor:
Devapiran Jaishankar, Fady Tawadros, Billy Brooks, Purva Sharma, Anna Yakubenko, Hemendra Mhadgut
Publikováno v:
Journal of Clinical Oncology. 39:e12554-e12554
e12554 Background: Breast cancer is a frequently diagnosed malignancy in the United States accounting for approximately 266,000 cases and 40,000 deaths annually. Human epidermal growth factor receptor 2 (HER2) is a surface protein shown to affect cel
Publikováno v:
BMJ Case Rep
A 67-year-old male patient presents to the hospital complaining of severe nausea and vomiting failing oral antiemetics. He carries the history of initial diagnosis of stage III prostate cancer. He underwent radical prostatectomy followed by external
Publikováno v:
American Journal of Therapeutics. 25:e598-e599
Publikováno v:
Oncology Reviews
Oncology Reviews, Vol 11, Iss 1 (2017)
Oncology Reviews, Vol 11, Iss 1 (2017)
Induction of apoptosis in cancer cells has increasingly been the focus of many therapeutic approaches in oncology field. Since its identification as a TNF family member, TRAIL (TNF-related apoptosis-inducing ligand) paved a new path in apoptosis indu
Autor:
Fady Tawadros, Muhammad Zahid Qureshi, Donald J. Buchsbaum, George E. Naoum, Waleed Arafat, Ammad Ahmad Farooqi, Sobia Tabassum
Publikováno v:
ecancermedicalscience
Since its identification as a member of the tumour necrosis factor (TNF) family, TRAIL (TNF-related apoptosis-inducing ligand) has emerged as a new avenue in apoptosis-inducing cancer therapies. Its ability to circumvent the chemoresistance of conven